CareDx, Inc. Cash and Equivalents

Quick Answer

CareDx, Inc. reported Cash and Equivalents of $65.43 million for fiscal year 2025.

CareDx, Inc. Cash and Equivalents — Annual History

Fiscal Year Cash and Equivalents YoY Change
2025 $65.43M -43.0%
2024 $114.69M +39.5%
2023 $82.20M -8.6%
2022 $89.92M -74.2%
2021 $348.49M +158.8%
2020 $134.67M +252.3%
2019 $38.22M -40.8%
2018 $64.62M +282.5%
2017 $16.89M -2.1%
2016 $17.26M -42.3%
2015 $29.89M -18.0%
2014 $36.43M +610.4%
2013 $5.13M -12.0%
2012 $5.83M +147.3%
2011 $2.36M

Quarterly Cash and Equivalents

Quarter Ending Cash and Equivalents YoY QoQ
September 30, 2025 $91.44M -4.2% +34.0%
June 30, 2025 $68.21M -28.8% -23.1%
March 31, 2025 $88.75M -4.9% -22.6%
December 31, 2024 $114.69M +39.5% +20.2%
September 30, 2024 $95.40M +25.6% -0.4%
June 30, 2024 $95.78M +9.1% +2.7%
March 31, 2024 $93.30M +25.0% +13.5%
December 31, 2023 $82.20M -8.6% +8.2%
  • CareDx, Inc. showed a decrease of -43.0% in Cash and Equivalents compared to the prior fiscal year.
  • Over the 2011–2025 period, CareDx, Inc.’s cash and equivalents has grown by 2675.9% (from $2.36 million to $65.43 million).
  • The most recent figure is from CareDx, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment